Blackstone cures two ailments in one Moderna shot [Reuters]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Reuters
NEW YORK, March 27 (Reuters Breakingviews) - Lending to a company is fine; taking a piece of its most promising investments is better. With higher costs of capital making spending decisions tougher for chief executives and buyout firms simultaneously struggling to invest stockpiles of cash, the deal , opens new tab between Blackstone (BX.N) , opens new tab and Moderna (MRNA.O) , opens new tab unveiled on Wednesday offers a crafty cure. The hard end of such bargains: surrendering value from potentially lucrative developments. Big money managers like Blackstone have amassed a combined $3.7 trillion, according , opens new tab to consultancy McKinsey, but a prolonged deal slump indicates how hard it is to put the funds to work. The firm led by Steve Schwarzman, for example, deployed 39% less last year than it did in 2022. Corporate bosses face the opposite problem. It's expensive to borrow, and equity markets have been equally inhospitable for drugmakers with lottery-ticket business mo
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing [Yahoo! Finance]Yahoo! Finance
- U.K. Tests World-First Personalized Skin Cancer Vaccine [Forbes]Forbes
- Should You Buy Moderna Before May 12? [Yahoo! Finance]Yahoo! Finance
- Sunil Wadhwa Joins Kong as Chief Customer Officer [Yahoo! Finance]Yahoo! Finance
- Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 2/22/24 - Beat
MRNA
Sec Filings
- 4/26/24 - Form 4
- 4/24/24 - Form 144
- 4/19/24 - Form 4
- MRNA's page on the SEC website